ITCI - Intra-Cellular Therapies Inc. Biznesning balans bahosi

Ommaviy kompaniya Intra-Cellular (ITCI) logotipi

Intra-Cellular Therapies (ITCI) Caplyta dorisini umumiy tibbiy amaliyotga integratsiya qilish orqali psixiatrik patologiyalarga qarshi kurashish uchun keng qamrovli muhit yaratmoqda. Aktivning 1.15 ga yetgan bozor qiymati dinamikasi zararli emissiyalarni kamaytirayotgan va bioetik standartlarga rioya qilayotgan kompaniyaga bo'lgan qiziqishni tasdiqlaydi. Bundan tashqari, biznes katta ma'lumotlar tahlili uchun dasturiy botlarni joriy etmoqda va laboratoriya molekulyar skriningini avtomatlashtirmoqda.

ITCI Intra-Cellular Balans kapitallashuvi (04.07.2022 - 13.04.2025)

Intra-Cellular (ITCI) kompaniyasi koʻrsatkichlari kesimi va tahlili

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Intra-Cellular Therapies|ITCI - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi Intra-Cellular Therapies Inc.|ITCI - Kompaniyaning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga xususiy kapital Intra-Cellular Therapies|ITCI - Balans kapitallashuvi|Bozor qiymatining balans qiymatiga koeffitsiyenti intracellulartherapies.com|ITCI - Kompaniyaning yakuniy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Intra-Cellular Therapies|ITCI - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Intra-Cellular Therapies|ITCI - Kompaniya qarzlari|Balans qiymatiga qarzlar Intra-Cellular Therapies Inc.
Kompaniyaning jamlanma tahlili:ITCI - Intra-Cellular Therapies, Inc.
intracellulartherapies.com yetakchi tovari

Intra-Cellular Therapies (ITCI) kompaniyasining Caplyta ishlab chiqarishini autsorsing qilish strategiyasi asosiy aktivlarni intellektual mulk sohasiga o'tkazish orqali kapital xarajatlarini minimallashtiradi. Kitob kapitalizatsiyasi barcha aktivlar va majburiyatlar o'rtasidagi farqni o'lchaydi hamda moliyaviy barqarorlikning bazaviy ko'rsatkichi sifatida sof aktiv qiymatini aks ettiradi. Kompaniyaga tegishli kitob kapitalizatsiyasi tarixini tahlil qilish orqali investor biznesning haqiqiy xavfsizlik zaxirasini va salbiy ssenariylar ostida kapitalning yo'qolish xavfini aniqlaydi.

Intra-Cellular Therapies kimlar bilan raqobatlashadi

BIIB - Kompaniyaning sof aktivlari|Neurocrine Biosciences - Balans kapitallashuvi|RGC (regencellbioscience.com) - Biznesning balans bahosi|Kompaniyaning balans qiymati Axsome Therapeutics, Inc. (AXSM)|Buxgalteriya kapitallashuvi ACADIA Pharma|Xenon Pharmaceuticals Inc - Balans kapitallashuvi|Kompaniyaning xususiy kapitali Viking Therapeutics Corp VKTX|Kompaniyaning sof aktivlari SUPN (Supernus Pharmaceuticals)|catalystpharma.com - Balans kapitallashuvi|Kompaniyaning balans qiymati Denali Therapeutics Inc. (DNLI)|HRMY: Kompaniyaning buxgalteriya qiymati|Kompaniyaning balans qiymati BHVN|Amylyx Corp (AMLX) - Kompaniyaning xususiy kapitali|TRVI: Balans kapitallashuvi|Biznesning balans bahosi PRAX|Kompaniyaning balans qiymati Anavex Life Sciences Corp. AVXL|Buxgalteriya kapitallashuvi CeriBell Inc CBLL|Kompaniyaning sof aktivlari prothena.com (PRTA)|Alector Inc. - Jami sof aktivlar|Kompaniyaning balans qiymati Annexon, Inc. (ANNX)|OMER - Kompaniyaning buxgalteriya qiymati|NGNE: Balans kapitallashuvi|Balans kapitallashuvi AC Immune S.A.|Voyager Pharma - Kompaniyaning sof aktivlari|Biznesning balans qiymati Neumora Corp|Balans kapitallashuvi SCLX (Scilex Holding Company)|Kompaniyaning sof aktivlari tevogen.com (TVGN)|ACOG: Balans kapitallashuvi|cogrx.com - Kompaniyaning xususiy kapitali|IKT - Kompaniyaning balans qiymati|SAVA: Kompaniyaning balans qiymati|assertiotx.com (ASRT) - Kompaniyaning balans qiymati|Kompaniyaning balans qiymati Coya Therapeutics|VTGN (VistaGen Therapeutics, Inc.) - Kompaniyaning sof aktivlari|Balans kapitallashuvi OVID|Kompaniyaning balans qiymati Acumen Pharma (ABOS)|Kompaniyaning balans qiymati CervoMed Corporation (CRVO)|Balans kapitallashuvi ATHE (Alterity Therapeutics Limited)|Clene Inc - Balans kapitallashuvi|Kompaniyaning balans qiymati PepGen Corp (PEPG)|jupiterneurosciences.com (JUNS) - Kompaniyaning buxgalteriya qiymati|Kompaniyaning sof aktivlari Relmada RLMD|Kompaniyaning buxgalteriya qiymati Annovis Bio Corporation|Grace Therapeutics Inc (GRCE) - Kompaniyaning sof aktivlari|Jami sof aktivlar fireflyneuro.com|Klotho Neurosciences Inc (KLTO) - Balans kapitallashuvi|Kompaniyaning buxgalteriya qiymati neurosense-tx.com (NRSN)|RVPH: Balans kapitallashuvi|MetaVia Inc. - Kompaniyaning xususiy kapitali|Kompaniyaning balans qiymati NeurAxis, Inc. (NRXS)|HSDT - Kompaniyaning buxgalteriya qiymati|PASG: Balans kapitallashuvi|NEUP (Neuphoria Therapeutics) - Balans kapitallashuvi|Kompaniyaning balans qiymati Minerva Neurosciences Corp NERV|Sof aktivlar qiymati Athira Pharma Corp|ADXN (Addex Therapeutics) - Balans kapitallashuvi|Biznesning balans bahosi alzamend.com (ALZN)|CYCN: Balans kapitallashuvi|Protagenic Therapeutics Inc. - Kompaniyaning xususiy kapitali|Kompaniyaning balans qiymati KTTA (Pasithea)|CRGT - Biznesning balans bahosi|Avenue Therapeutics - Balans kapitallashuvi|Biznesning balans bahosi brainstorm-cell.com|Cara Therapeutics (CARA) - Kompaniyaning sof aktivlari|Jami sof aktivlar Chromocell Therapeutics Corp|Balans kapitallashuvi ELYM (Eliem Therapeutics)|Kompaniyaning sof aktivlari Longboard (LBPH)|Balans kapitallashuvi MRNS|nkgenbiotech.com - Biznesning balans bahosi|NeuroBo Pharmaceuticals, Inc. (NRBO) - Kompaniyaning balans qiymati|SAGE - Buxgalteriya kapitallashuvi|Balans kapitallashuvi SNPX|Kompaniyaning xususiy kapitali Trevena Inc|VIGL (Vigil Neuroscience Inc.) - Kompaniyaning sof aktivlari|Balans kapitallashuvi WENA|Cerevel Therapeutics, Inc. (CERE) - Kompaniyaning balans qiymati